Scope of the Report
The report entitled Global Cancer Diagnostic Market with Focus on Lung and Breast Cancer (2016-2020), provides analysis of the global cancer diagnostics market and the US cancer diagnostics market, with detailed analysis of market size and growth, penetration and market share. The report also provides the analysis of the global and the US cancer market, by prevalence, new cases, deaths, type of cancers, etc. The report provides the market sizing of the global lung and breast cancer diagnostic market by value and by segments.
The report also discusses about the different diagnostic test of lung cancer and breast cancer. The diagnostics test analyzed in the report are: MetaStat (Meta Test) (Breast Cancer Test), OncotypeDX (Breast Cancer Test), OncoCyte (Lung Cancer Test), Veracytes Test (Lung Cancer Test) and Integrated Diagnostics, Inc. Test (Lung Cancer Test).
North America (US)
A disease caused by abnormal growth of cells in the body, is called Cancer. In this disease, the formation of new cells slows or start dividing, forming lumps. However, all lumps are not cancerous; and this can be known by diagnosis.
There are various types of cancer- prostate cancer, breast cancer, lung and bronchus cancer, colon and rectum cancer, bladder cancer, melanoma of the skin, non-hodgkin lymphoma, kidney and renal, pelvis cancer, thyroid cancer, endometrial cancer and others.
Cancer is diagnosed using various tools, which confirm the presence of tumour, and the rate of its growth within the body. Cancer diagnosis can be segmented into: imaging testing, endoscopy, biopsy and tumour marker. Each segment can be sub segmented.
The global cancer diagnostic market is expected to increase at a significant growth rate during the forecasted period (2016-2020). The global cancer diagnostic market is supported by various growth drivers, such as the rising incidence of cancer, sedentary lifestyle, growing technological advancement, increasing awareness, etc.
1. Executive Summary
2.1 Cancer Overview
2.2 Cancer Diagnostic: Overview
2.3 Cancer Diagnostic: Liquid Biopsy
3. Market Analysis
3.1 Cancer Prevalence Analysis
3.1.1 Global Cancer New Cases and Death
3.1.2 Global Cancer Prevalence, New Cases and Death by Type
3.1.3 US Cancer Prevalence
3.1.4 US Cancer New Cases and Death by Type
3.2 Cancer Diagnostic Market Analysis
3.2.1 Global Cancer Diagnostic Market by Value
3.2.2 Global Cancer Diagnostic Market by Segments (Type of Tests)
3.2.3 Global Cancer Diagnostic Market by Segments (Type of Cancer)
3.2.4 Global Cancer Diagnostic Market by Region
3.2.5 North America Cancer Diagnostic Market by Value
3.3 Lung Cancer Diagnostic Market Analysis
3.3.1 Global Lung Cancer Diagnostic Market by Value
3.3.2 Global Lung Cancer Diagnostic Market by Segment (Type of Test)
3.3.3 Global Lung Cancer Cases by Type
3.4 Breast Cancer Diagnostic Market Analysis
3.4.1 Global Breast Cancer Diagnostic Market by Value
3.5 MetaStat (Meta Test) Analysis (Breast Cancer Test)
3.5.1 Mena Testing: An Overview
3.5.2 Mena Breast Cancer Test Market Opportunity (US)
3.5.3 US Mena Test Market Opportunity
3.5.4 US Mena Test Market by Number of Test and Addressable Population
3.6 OncotypeDX (Breast Cancer Test)
3.6.1 OncotypeDX by Addressable Market
3.7 OncoCyte (Lung Cancer Test)
3.7.1 OncoCyte Test by Average Price and Revenue
3.7.2 OncoCyte Test by Test Volume and Market Penetration
3.8 Veracytes Test (Lung Cancer Test)
3.8.1 Veracytes Percepta Test Overview
3.9 Integrated Diagnostics, Inc. Test (Lung Cancer Test)
3.9.1 Integrated Diagnostics, Inc. Test Overview